Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides

Journal of the American Academy of Dermatology

Volumn 60, Issue 2, 2009, Pages 231-235

  Sun, Grace ^a   Berthelot, Cindy ^a   Li, Yafang ^b   Glass II, Donald A ^c   George, Dornechia ^c   Pandya, Amit ^c   Kurzrock, Razelle ^b   Duvic, Madeleine ^a  

^a University of Texas Health Science Center at Houston   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ALLOTRANSPLANTATION; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER SURVIVOR; CANCER THERAPY; CAUCASIAN; CHI SQUARE TEST; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE SEVERITY; FEMALE; HISPANIC; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGE OF ONSET; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; TEXAS;

EID: 58149490970     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.09.063     Document Type: Article

References (15)

1. Criscione V.D., and Weinstock M.A. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 143 (2007) 854-859
2. Weinstock M.A., and Horm J.W. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 260 (1988) 42-46
3. Crowley J.J., Nikko A., Varghese A., Hoppe R.T., and Kim Y.H. Mycosis fungoides in young patients: clinical characteristics and outcome. J Am Acad Dermatol 38 (1998) 696-701
4. Quaglino P., Zaccagna A., Verrone A., Dardano F., and Bernengo M.G. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course. Dermatology 199 (1999) 8-14
5. Weinstock M.A., and Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 89 (1999) 1240-1244
6. Maor M.H., Velasquez W.S., Fuller L.M., and Silvermintz K.B. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol 8 (1990) 266-271
7. Velasquez W.S., McLaughlin P., Tucker S., Hagemeister F.B., Swan F., Rodriguez M.A., et al. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 12 (1994) 1169-1176
8. Duvic M. Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies. Oncology (Huntingt) 21 Suppl (2007) 33-40
9. Duvic M., and Vu J. Vorinostat in cutaneous T-cell lymphoma. Drugs Today (Barc) 43 (2007) 585-599
10. Koch S.E., Zackheim H.S., Williams M.L., Fletcher V., and LeBoit P.E. Mycosis fungoides beginning in childhood and adolescence. J Am Acad Dermatol 17 (1987) 563-570
11. Stone M.L., Styles A.R., Cockerell C.J., and Pandya A.G. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 67 (2001) 133-138
12. Akaraphanth R., Douglass M.C., and Lim H.W. Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients. J Am Acad Dermatol 42 (2000) 33-39
13. Whitmore S.E., Simmons-O'Brien E., and Rotter F.S. Hypopigmented mycosis fungoides. Arch Dermatol 130 (1994) 476-480
14. Diamandidou E., Colome M., Fayad L., Duvic M., and Kurzrock R. Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 40 (1999) 914-924
15. Diamandidou E., Colome-Grimmer M., Fayad L., Duvic M., and Kurzrock R. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood 92 (1998) 1150-1159